Recruitment

Recruitment Status
Completed
Estimated Enrollment
66

Inclusion Criterias

a primary diagnosis of OCD as defined by DSM-5
ability to read and write Swedish
a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
...
a primary diagnosis of OCD as defined by DSM-5
ability to read and write Swedish
a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
daily access to the internet
a parent that is able to co-participate in the treatment
age between 12 and 17 years

Exclusion Criterias

completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
ongoing psychological treatment for OCD or another anxiety disorder
subject not able to read or understand the basics of the ICBT material
...
completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
ongoing psychological treatment for OCD or another anxiety disorder
subject not able to read or understand the basics of the ICBT material
diagnosed autism spectrum disorder, psychosis or bipolar disorder, severe eating disorder
suicidal ideation
ongoing substance dependence

Summary

Conditions
Obsessive-Compulsive Disorder
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 12 years and 17 years
Gender
Both males and females

Description

The primary objective of this study is to test the efficacy of Internet-delivered cognitive behavior therapy (ICBT) for adolescents (12 - 17 years) with OCD. We aim to conduct a randomized controlled study with N = 66 participants. Participants will be randomly assigned to ICBT or a wait list condit...

The primary objective of this study is to test the efficacy of Internet-delivered cognitive behavior therapy (ICBT) for adolescents (12 - 17 years) with OCD. We aim to conduct a randomized controlled study with N = 66 participants. Participants will be randomly assigned to ICBT or a wait list condition, either lasting 12 weeks. The primary outcome measure is the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Study participants will be followed up 3 and 12 months after treatment. ICBT is expected to yield significantly better symptom reduction than the wait list condition.

Inclusion Criterias

a primary diagnosis of OCD as defined by DSM-5
ability to read and write Swedish
a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
...
a primary diagnosis of OCD as defined by DSM-5
ability to read and write Swedish
a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
daily access to the internet
a parent that is able to co-participate in the treatment
age between 12 and 17 years

Exclusion Criterias

completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
ongoing psychological treatment for OCD or another anxiety disorder
subject not able to read or understand the basics of the ICBT material
...
completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
ongoing psychological treatment for OCD or another anxiety disorder
subject not able to read or understand the basics of the ICBT material
diagnosed autism spectrum disorder, psychosis or bipolar disorder, severe eating disorder
suicidal ideation
ongoing substance dependence

Locations

Stockholm, 171 77
Stockholm, 171 77

Tracking Information

NCT #
NCT02191631
Collaborators
Not Provided
Investigators
  • Principal Investigator: Eva Serlachius, MD, PhD Karolinska Institutet
  • Eva Serlachius, MD, PhD Karolinska Institutet